Clinical Trials List
Protocol NumberCC-220-DLBCL-002
2021-08-01 - 2021-09-27
Phase I/II
Terminated2
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- - - 無
- Huai-Hsuan Huang 無
- SHAN-CHI YU 無
- - - 無
- HSIN-AN HOU 無
- Sheng-chieh Chou 無
- 劉高郎 無
- Wen-Chien Chou 無
- Chieh-Lung Cheng 無
- Chien-Chin Lin 無
- KUAN-YIN KO 無
- MING YAO 無
- 田豐銘 無
- CHENG-HONG TSAI 無
- WEI-LI MA 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
252 participants
